Literature DB >> 26694770

Analyses of herpes simplex virus type 1 latency and reactivation at the single cell level using fluorescent reporter mice.

J T Proença1, D Nelson2, M P Nicoll3, V Connor2, S Efstathiou3.   

Abstract

Herpes simplex virus type 1 (HSV-1) establishes a latent infection in sensory neurons from which the virus can periodically reactivate. Whilst latency establishment is thought to result from a failure to express immediate-early genes, we have previously shown that subpopulations of the latent neuronal reservoir have undergone lytic promoter activation prior to latency establishment. In the present study, we have investigated the biological properties of such latently infected neuronal subpopulations using Ai6 fluorescent reporter mice. Using this system we have determined that prior ICP0 or TK promoter activation does not correlate with increased latent virus DNA loads within individual cells and that neurons with evidence of historical lytic cycle promoter activity exhibit a comparable frequency of reactivation to that of the general latent cell population. Comparison of viral DNA content within cells harbouring latent HSV-1 genomes and those undergoing the earliest stages of reactivation has revealed that reactivation can initiate from cells harbouring a wide range of HSV-1 genome copies, but that exiting latency is biased towards cells bearing higher latent virus DNA loads.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26694770      PMCID: PMC5381395          DOI: 10.1099/jgv.0.000380

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  32 in total

1.  Scale: a chemical approach for fluorescence imaging and reconstruction of transparent mouse brain.

Authors:  Hiroshi Hama; Hiroshi Kurokawa; Hiroyuki Kawano; Ryoko Ando; Tomomi Shimogori; Hisayori Noda; Kiyoko Fukami; Asako Sakaue-Sawano; Atsushi Miyawaki
Journal:  Nat Neurosci       Date:  2011-08-30       Impact factor: 24.884

Review 2.  Experimental investigation of herpes simplex virus latency.

Authors:  E K Wagner; D C Bloom
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

3.  Comprehensive quantification of herpes simplex virus latency at the single-cell level.

Authors:  N M Sawtell
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Laser-capture microdissection: refining estimates of the quantity and distribution of latent herpes simplex virus 1 and varicella-zoster virus DNA in human trigeminal Ganglia at the single-cell level.

Authors:  Kening Wang; Tsz Y Lau; Melissa Morales; Erik K Mont; Stephen E Straus
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  Regulation of ICP0-null mutant herpes simplex virus type 1 infection by ND10 components ATRX and hDaxx.

Authors:  Vera Lukashchuk; Roger D Everett
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

6.  Mechanisms of herpes simplex virus type 1 reactivation.

Authors:  W P Halford; B M Gebhardt; D J Carr
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

7.  CD8(+) T-cell attenuation of cutaneous herpes simplex virus infection reduces the average viral copy number of the ensuing latent infection.

Authors:  Linda M Wakim; Claerwen M Jones; Thomas Gebhardt; Christopher M Preston; Francis R Carbone
Journal:  Immunol Cell Biol       Date:  2008-07-08       Impact factor: 5.126

8.  Nucleotide sequence and organization of the mouse adenine phosphoribosyltransferase gene: presence of a coding region common to animal and bacterial phosphoribosyltransferases that has a variable intron/exon arrangement.

Authors:  M K Dush; J M Sikela; S A Khan; J A Tischfield; P J Stambrook
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

9.  An investigation of herpes simplex virus promoter activity compatible with latency establishment reveals VP16-independent activation of immediate-early promoters in sensory neurones.

Authors:  João T Proença; Heather M Coleman; Michael P Nicoll; Viv Connor; Christopher M Preston; Jane Arthur; Stacey Efstathiou
Journal:  J Gen Virol       Date:  2011-07-13       Impact factor: 3.891

10.  Herpesviruses carrying a Brainbow cassette reveal replication and expression of limited numbers of incoming genomes.

Authors:  Oren Kobiler; Yaron Lipman; Kate Therkelsen; Ingrid Daubechies; Lynn W Enquist
Journal:  Nat Commun       Date:  2010       Impact factor: 14.919

View more
  5 in total

1.  DLK-Dependent Biphasic Reactivation of Herpes Simplex Virus Latency Established in the Absence of Antivirals.

Authors:  Sara Dochnal; Husain Y Merchant; Austin R Schinlever; Aleksandra Babnis; Daniel P Depledge; Angus C Wilson; Anna R Cliffe
Journal:  J Virol       Date:  2022-05-24       Impact factor: 6.549

2.  The HSV-1 Latency-Associated Transcript Functions to Repress Latent Phase Lytic Gene Expression and Suppress Virus Reactivation from Latently Infected Neurons.

Authors:  Michael P Nicoll; William Hann; Maitreyi Shivkumar; Laura E R Harman; Viv Connor; Heather M Coleman; João T Proença; Stacey Efstathiou
Journal:  PLoS Pathog       Date:  2016-04-07       Impact factor: 6.823

3.  Viral Ubiquitin Ligase Stimulates Selective Host MicroRNA Expression by Targeting ZEB Transcriptional Repressors.

Authors:  Gabriel Lutz; Igor Jurak; Eui Tae Kim; Ju Youn Kim; Michael Hackenberg; Andrew Leader; Michelle L Stoller; Donna M Fekete; Matthew D Weitzman; Donald M Coen; Angus C Wilson
Journal:  Viruses       Date:  2017-08-07       Impact factor: 5.048

Review 4.  Pathogenesis and virulence of herpes simplex virus.

Authors:  Shuyong Zhu; Abel Viejo-Borbolla
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

5.  Tumor Necrosis Factor Alpha Induces Reactivation of Human Cytomegalovirus Independently of Myeloid Cell Differentiation following Posttranscriptional Establishment of Latency.

Authors:  Eleonora Forte; Suchitra Swaminathan; Mark W Schroeder; Jeong Yeon Kim; Scott S Terhune; Mary Hummel
Journal:  MBio       Date:  2018-09-11       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.